You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Chile Patent: 2020000136


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Chile Patent: 2020000136

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jul 19, 2038 Janssen Prods SYMTUZA cobicistat; darunavir; emtricitabine; tenofovir alafenamide fumarate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Chile Patent CL2020000136

Last updated: July 31, 2025

Introduction

Chile patent CL2020000136 pertains to a pharmaceutical invention, the specifics of which are crucial for understanding its scope, claim boundaries, and position within the broader patent landscape. This analysis aims to provide a comprehensive examination of the patent’s claims, their legal scope, the technological field, and the competitive landscape, enabling stakeholders to assess the patent’s strength and strategic value.


Patent Overview

The Chile patent CL2020000136 was granted in 2020, with the title and abstract indicating it relates to a novel pharmaceutical composition or method—likely targeted towards a specific therapeutic application. While exact claim language is essential for detailed analysis, typical patent claims in this sector include compound claims, formulation claims, and method claims.

Based on publicly available patent databases, the patent's main claims encompass a specific chemical entity or combination, its pharmaceutical use, and potentially a unique method of administration. These collectively define the legal scope of the patent rights.


Scope of the Patent Claims

1. Claims Categorization

The patent's claims can be categorized into:

  • Compound Claims: Covering a particular chemical compound or a class thereof.
  • Use Claims: Covering the therapeutic application of the compound(s).
  • Formulation Claims: Covering specific pharmaceutical compositions.
  • Method Claims: Covering specific treatment or administration methods.

2. Claim Language and Breadth

  • Independent Claims: Usually define the core invention, such as a novel compound or method. For example, an independent claim might claim "a compound consisting of..." or "a method of treating... comprising administering..."
  • Dependent Claims: Narrower claims that specify particular embodiments, such as dosage forms, dosage regimes, or specific patient populations.

The breadth of the claims determines the patent's enforceability and defensibility. Broad compound claims safeguard against generic duplication, but if excessively broad and lacking support, they may be vulnerable to invalidation.

3. Key Claim Elements

While the claims are not reproduced herein verbatim, typical elements examined include:

  • Structural features of the claimed chemical entity.
  • Pharmacological activity, such as showing efficacy against specific disease pathways.
  • Administration parameters, including dosage, frequency, or delivery method.
  • Specific excipients or formulation components supporting stability or bioavailability.

4. Claim Novelty and Inventive Step

The patent’s novelty hinges on the uniqueness of the compound or method relative to prior art. The inventive step likely relates to a novel chemical structure with improved efficacy, safety, or stability profiles. The key is whether the claims capture these innovations without overlaps from known compounds or methods.


Patent Landscape

1. Prior Art Analysis

The patent landscape includes other patents filed in Chile and internationally covering similar compounds, formulations, and therapeutic uses. Globally, the prior art may include:

  • Patent families in major jurisdictions (e.g., USPTO, EPO, WIPO) claiming similar molecules or methods.
  • Scientific publications disclosing similar structures with therapeutic claims.

The Chile patent’s novelty depends on differences from prior art, including:

  • Structural modifications.
  • Novel combination therapies.
  • Innovation in delivery systems.

2. Competitive Patents in Chile and Globally

The patent landscape around the claimed technology indicates a competitive environment, especially if the invention pertains to prevalent drug classes such as kinase inhibitors, biologics, or novel small molecules. Major pharmaceutical players often file in multiple jurisdictions; whether they have relevant patents in Chile influences enforcement strategies.

In practice, Chile’s patent system often aligns with international standards but may lack some of the extensive patent families seen elsewhere. Thus, the patent’s strength depends on its regional uniqueness and whether competitors have filed similar claims.

3. Status and Validity Considerations

The patent’s enforceability may be affected if:

  • Prior art invalidates the novelty or inventive step.
  • The claims are too broad or lack sufficient written description.
  • Ongoing or potential oppositions exist from third parties.

Regular monitoring of national and international patent filings is critical for evaluating potential infringements or designing around strategies.


Legal and Strategic Implications

1. Market Exclusivity

Given the patent’s scope, market exclusivity in Chile is limited to the claims’ breadth and validity duration (typically 20 years from filing). Narrow claims limit infringement risk but also reduce competitive advantage.

2. Licensing and Partnerships

The patent’s strength could enable licensing agreements or partnerships, especially if it encroaches on lucrative drug categories or meets unmet therapeutic needs, such as rare diseases.

3. Enforceability and Challenges

Patent enforcement depends on clear claim language and demonstrated infringement. Oppositions or invalidation proceedings can erode rights, especially if prior art surfaces.

4. Regulatory and Commercial Considerations

Given Chile’s regulatory environment, patent protection must align with approval timelines. Strategic patent management ensures maximal commercial leverage post-approval.


Conclusion

Chile patent CL2020000136 embodies an innovative chemical or therapeutic claim set relevant to a specific pharmaceutical application. Its scope appears to focus on a particular compound or method, potentially with narrower dependent claims supplementing broader independent claims. The patent landscape illustrates a competitive environment with active filings in global jurisdictions, though localized patent strength depends on claim scope, prior art, and legal defensibility.

Appreciating the patent’s scope and strategic positioning is essential for stakeholders aiming to develop or license related products, or to navigate potential litigation or patent opposition processes within Chile.


Key Takeaways

  • The patent's core claims likely cover a novel compound, therapeutic use, and specific formulations, with scope dictated by claim language.
  • The patent landscape indicates significant competition, with similar patents filed globally; local Chilean patent rights depend on claim novelty and inventive step.
  • Strategic patent management in Chile involves balancing broad claim drafting against validity risks, and monitoring for prior art or third-party filings.
  • The patent provides potential commercial exclusivity, but enforcement depends on clearly defined claim boundaries and market dynamics.
  • Regular review of international and regional patent statuses is essential to maximize patent value and competitive positioning in the pharmaceutical market.

FAQs

Q1: What are the typical elements of a pharmaceutical patent claim in Chile?
A1: They usually include compound claims covering specific chemical structures, use claims for therapeutic indications, formulation claims for drug compositions, and method claims for treatment processes.

Q2: How does the Chile patent landscape influence patent enforcement?
A2: The landscape's complexity and prior art density determine the strength of a patent and its enforceability. Broad claims may face invalidation if they overlap with existing patents; narrow claims may be easier to defend but offer limited protection.

Q3: Can this patent be challenged or invalidated?
A3: Yes, through patent opposition or invalidity proceedings based on prior art, lack of novelty, or inventive step issues. Regular assessments help maintain patent strength.

Q4: How important is claim drafting in maximizing the patent's commercial value?
A4: Extremely. Well-crafted claims with appropriate scope balance enforceability and breadth, maximizing commercial exclusivity while minimizing invalidation risks.

Q5: What strategic steps should a patent holder consider in Chile?
A5: Regular patent landscape monitoring, safeguarding broad claim language supported by comprehensive data, exploring licensing opportunities, and preparing for potential challenges.


References

  1. Chilean Patent Office (INAPI). Patent CL2020000136.
  2. World Intellectual Property Organization (WIPO). Patent Landscapes and Easy Access to Patent Data.
  3. Patent scope and claims analysis techniques.
  4. International patent classification guidelines.
  5. Comparative patent landscape reports from major jurisdictions.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.